Molecular Assessment for Gastro-Esophageal Cancer
NCT06346054 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000
Last updated 2026-02-17
Summary
The goal of this minimally invasive interventional study is to learn if oncometabolic biomarkers, detected in the exhaled breath and blood can identify early-stage gastro-oesophageal cancer in patient at risk for gastro-oesophageal cancer.
The main questions this study aims to answer:
Are oncometabolites proficient and reproducible enough to function as diagnostic biomarkers? Can these biomarkers identify early-stage gastro-esophageal cancer? Researchers will compare participants with gastro-oesophageal cancer to healthy controls and participants with Barrett's esophagus to detect meaningful differences between the groups.
Participants will provide a breath and blood sample during their routine standard of care visits.
Conditions
- Esophageal Cancer
- Gastric Cancer
- Barrett Esophagus
Interventions
- DIAGNOSTIC_TEST
-
Breath analysis
Detection of proteins and volatile organic compounds (oncometabolites) in the exhaled breath
- DIAGNOSTIC_TEST
-
Blood analysis
Detection of proteins and circulating tumor DNA (oncometabolites) in the peripheral blood
Sponsors & Collaborators
-
KU Leuven
lead OTHER
Principal Investigators
-
Stijn Vanstraelen, MD · Universitaire Ziekenhuizen KU Leuven
-
Philippe Nafteux, MD, PhD · Universitaire Ziekenhuizen KU Leuven
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-08-01
- Primary Completion
- 2029-07-01
- Completion
- 2029-07-01
Countries
- Belgium
Study Locations
More Related Trials
-
Novel Biomarkers in the Neoplastic Progression of Barrett's Esophagus
NCT00431756 ·Status: ACTIVE_NOT_RECRUITING
-
Liquid Biopsies in Esophageal Cancer
NCT05704530 ·Status: RECRUITING ·Phase: NA
-
Esophageal Cancer Risk Registry
NCT00260585 ·Status: RECRUITING
-
Evaluation of MicroRNA Expression in Blood and Cytology for Detecting Barrett's Esophagus and Associated Neoplasia
NCT02464930 ·Status: UNKNOWN
-
Effectiveness of Risk-based Sequential Screening for Esophageal and Gastric Cancer
NCT06306755 ·Status: RECRUITING ·Phase: NA
-
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry
NCT00574327 ·Status: RECRUITING
-
Minimally Invasive Molecular Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Adenocarcinoma
NCT03961945 ·Status: RECRUITING ·Phase: NA
-
Enhancing Screening Practices for BE
NCT07335445 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Effects of Sorafenib on Molecular Barrett's Esophagus Cancer
NCT00619242 ·Status: TERMINATED ·Phase: NA
-
Efficacy of EsoGuard on Samples Collected Using EsoCheck Versus EGD for the Diagnosis of BE
NCT04293458 ·Status: COMPLETED ·Phase: NA
-
Erlotinib in Treating Patients With Barrett Esophagus
NCT00566800 ·Status: UNKNOWN ·Phase: PHASE1
-
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
NCT02560623 ·Status: COMPLETED ·Phase: NA
-
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
NCT00288119 ·Status: RECRUITING
-
The Microenvironment in Barrett's Esophagus
NCT03060642 ·Status: COMPLETED
-
Longitudinal Study on the Evolution Trend and Influencing Factors of Postoperative Reflux of Esophageal Cancer Based on PEPTEST Technique
NCT06509022 ·Status: ENROLLING_BY_INVITATION
-
Profiling Microbiome Associated Metabolic Pathways in Oesophageal Cancer Survivors
NCT06302660 ·Status: ACTIVE_NOT_RECRUITING
-
Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus
NCT00003076 ·Status: COMPLETED ·Phase: PHASE2
-
Epidemiology of Barrett's Esophagus: A Population Based Study
NCT01286155 ·Status: COMPLETED
-
Minimally Invasive Approaches for the Diagnosis of Barrett's Esophagus and Esophageal Cancer, SOS5C Trial
NCT07206589 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Confocal Endomicroscopy for Improved Diagnosis of Barrett's Esophagus and Early Esophageal Cancer(CEBE Study)
NCT01124214 ·Status: COMPLETED ·Phase: NA
-
Preliminary Longitudinal Validation of Biomarkers Predictive of Barrett's Esophagus
NCT00844077 ·Status: COMPLETED
-
Endoscopic Therapy of Early Cancer in Barretts Esophagus
NCT00217087 ·Status: COMPLETED ·Phase: PHASE2
-
Stratifying Risk in Barrett's Esophagus: A Pilot Study for Biomarker-based Patient Management
NCT02075905 ·Status: COMPLETED
-
The Use of Biomarkers to Guide Management of Patients Treated With Radiofrequency Ablation for Early Oesophageal Neoplasia
NCT04155242 ·Status: RECRUITING ·Phase: NA
-
CIRCULATing Biomarkers for Individualized Surgical Therapy in gastroEsophageal Cancer - Phase 1
NCT04455282 ·Status: RECRUITING